New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5273 | Bengamide B | Potent inhibitor of NF-κB activation |
| 5131 | NAB 2 | Protects against α-synuclein toxicity; promotes Rsp5/Nedd4-dependent endosomal transport |
| 4941 | PKI 166 hydrochloride | Potent EGFR-kinase inhibitor |
| 4793 | CE3F4 | Uncompetitive Epac1 inhibitor |
| 5374 | GLP-1 (7-37) | Endogenous bioactive GLP-1 receptor ligand |
| 5373 | C34 | TLR4 inhibitor |
| 5337 | ML 365 | Potent and selective TASK-1 channel blocker |
| 5326 | CHR 6494 trifluoroacetate | Potent and selective haspin kinase inhibitor |
| 5321 | PSNCBAM-1 | CB1 receptor negative allosteric modulator |
| 5271 | UNC 3230 | Potent and selective PIP5K1C inhibitor; antinociceptive |
| 5000 | FTIDC | Potent and selective negative allosteric modulator at mGlu1; also mGlu1 inverse agonist |
| 4943 | UNC 1999 | Potent and selective EZH2/EZH1 histone lysine methyltransferase inhibitor |
| 4827 | Garcinol | PCAF/p300 HAT inhibitor; anticancer |
| 5400 | (S)-PFI 2 hydrochloride | Negative control of (R)-PFI 2 hydrochloride (Cat. No. 4892) |
| 5384 | TA 02 | Induces cardiomyocyte differentiation from hESCs |
| 5383 | TA 01 | Induces cardiomyocyte differentiation from hESCs |
| 5345 | ML 348 | Selective and reversible lysophospholipase 1 (LYPLA1) inhibitor |
| 5331 | CPI 203 | BET bromodomain inhibitor; arrests cell cycle at G1 phase |
| 5284 | trans-ISRIB | Integrated stress response (ISR) inhibitor |
| 5197 | Spautin 1 | USP10 and USP13 inhibitor; inhibits autophagy |
| 5108 | TFC 007 | Potent hematopoietic prostaglandin D synthase (H-PGDS) inhibitor |
| 5080 | TC-G 1003 | High affinity somatostatin sst2 receptor agonist |
| 5009 | BMS 509744 | Potent and selective ITK kinase inhibitor |
| 4695 | Ischemin sodium salt | CBP bromodomain inhibitor; cell permeable |